When was Afaxys founded?

Afaxys was founded in 2008 and raised its 1st funding round 17 years after it was founded.

Where is Afaxys located?

Afaxys is headquartered in Charleston, United States.

Who is the current CEO of Afaxys?

Ronda Dean of Afaxys. They have also founded 1 company.

How many employees does Afaxys have?

As of Dec 31, 2022, the latest employee count at Afaxys is 39.

Is Afaxys a funded company?

Afaxys is a funded company, having raised a total of $3M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 04, 2025.

When was the latest funding round of Afaxys?

Afaxys' latest funding was a $***** Seed round on Aug 04, 2025, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $260M in funding in 2026 to date.

Where does Afaxys rank among its competitors?

Afaxys ranks 22nd amongst 1104 active competitors, of which 36 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Afaxys, which secured $5M in Aug, 2025.

Who are the top competitors of Afaxys?

Afaxys' top competitors include Akums, Rubicon and Jubilant Life Sciences. Among them, Afaxys secured the most recent funding round in August, 2025.

Afaxys - 2026 Company Profile, Team, Funding & Competitors

Afaxys is a seed company based in Charleston (United States), founded in 2008 by Ronda Dean. It operates as an Affordable sexual and reproductive healthcare access for all, mission-driven. Afaxys has raised $3M in funding. The company has 1104 active competitors, including 36 funded and 160 that have exited. Its top competitors include companies like Akums, Rubicon and Jubilant Life Sciences.

Company Details

Affordable sexual and reproductive healthcare access for all, mission-driven. This public benefit corporation focuses on ensuring affordable access to sexual and reproductive healthcare as a right, not a privilege. They deliver a full range of contraceptive options and source products and services that providers need at discounted pricing. The company partners with those who serve public health patients, contributing to a healthier, empowered, and just society. They offer exclusive pricing and extensive access to products and services from nationally recognized manufacturers through their GPO and online marketplace. Their mission is driven by values like customer focus, integrity, collaboration, solution orientation, and quality. They aim to be a trusted women’s healthcare partner, providing dependable supply and stable pricing.

Website: www.afaxys.com/
Social
Phone Number: +1 **********

Key Metrics

Founded Year

2008

Location

Charleston, United States

Stage

Seed

Total Funding

$3M in 2 rounds

Latest Funding Round

Seed, Aug 04, 2025, $*****

Investors

The David and Lucile Packard Foundation

Ranked

22^nd among 1104 active competitors

Employee Count

39 as on Dec 31, 2022

Similar Companies

Halewood Laboratories & 265 more

View Afaxys' full profile

Afaxys is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
AFAXYS, INC. CIN: 262550461 , United States, Active	Dec 31, 1999	-	39 (As on Dec 31, 2022)	-
Afaxys, Inc CIN: 26-2550461 , United States, Active	Dec 31, 2007	-	-	-

Afaxys has raised a total funding of $3M over 2 rounds. Its first funding round was on Aug 04, 2025. Its latest funding round was a Seed round on Aug 04, 2025 for $*****. 1 investor participated in its latest round. Afaxys has 1 institutional investor.

Here is the list of recent funding rounds of Afaxys:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 04, 2025	9316722	Seed	5265676	1186172	3008476	9900613
Aug 04, 2025	6947822	Grant (prize money)	7785565	3780555	7719012	1808198

Access funding benchmarks and valuations. Sign up today!

View details of Afaxys's funding rounds and investors

The founders of Afaxys is Ronda Dean. Ronda Dean is the CEO of Afaxys.

Here are the details of Afaxys' key team members:

Ronda Dean: Founder & CEO of Afaxys.

View details of Afaxys's Founder profiles and Board Members

Afaxys' employee count trend

Afaxys has 39 employees as of Dec 22. Here is Afaxys's employee count trend over the years:

Uncover Afaxys' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Afaxys include Akums, Rubicon and Jubilant Life Sciences. Here is the list of Top 10 competitors of Afaxys, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Akums 2004, Delhi (India), Public	CDMO focusing on spectrum of dosage forms and therapeutic segments	$70M	Quadria Capital & 5 others	60/100
2nd	Rubicon 2000, Mumbai (India), Public	CDMO offering drug development services through its proprietary drug delivery technologies	$4.62M	Kotak Private Equity Group, Kotak Mahindra Bank ... & 3 others	60/100
3rd	Jubilant Life Sciences 1978, Noida (India), Public	Company offering a suite of R&D and manufacturing services for small molecules and generics	-	Samena Capital, General Atlantic & 1 others	59/100
4th	Recipharm 1995, Jordbro (Sweden), Acquired	Contract services for pharmaceutical development and manufacturing	-	CPP Investments, Ampersand Capital	57/100
5th	Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired	Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution	$31M	Telegraph Hill Partners, BizCap & 1 others	57/100
6th	Nectar Lifesciences 1995, Chandigarh (India), Public	Manufacturer of cephalosporin APIs and generic formulations	$46.9M	Vedanta Capital, NSR Partners & 1 others	56/100
7th	Ipca Laboratories 1949, Mumbai (India), Public	Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and generic medications	-	ChrysCapital	56/100
8th	SAVA group 2003, Pune (India), Unfunded	Pharma company with a portfolio of domestic and export products, also offering CRAMS services	-	-	56/100
9th	Halewood Laboratories 1984, Ahmedabad (India), Unfunded	Manufacturer of pharmaceutical, food, and beverage products via contract manufacturing	-	-	55/100
10th	Supriya Lifescience 2008, Mumbai (India), Public	Manufacturer of active pharmaceutical ingredients and finished dosage formulations for healthcare	-	-	54/100
22nd	Afaxys 2008, Charleston (United States), Seed	Affordable sexual and reproductive healthcare access for all, mission-driven	$3M	The David and Lucile Packard Foundation	50/100